István A. Krizbai

István A. Krizbai

Auto-generated profile, based on publicly available information

István A. Krizbai

Institute of Biophysics, Biological Research Center, Szeged, Hungary

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2011 in Acta Neurobiologiae Experimentalis
Verified
Journal Article
Open access
PDF file
IWImola Wilhelm
Imola Wilhelm
CFCsilla Fazakas
Csilla Fazakas
IKIstvan Krizbai
Istvan Krizbai
The blood-brain barrier (BBB) is an active interface between the circulation and the central nervous system (CNS) with a dual function: the barrier function restricts the transport from the blood to the brain of potentially toxic or harmful substances; the carrier function is responsible for the transport of nutrients to the brain and removal of metabolites. The BBB plays a crucial role in the clinical practice as well. On the one side there is a large number of neurological disorders including cerebral ischemia, brain trauma and tumors, neurodegenerative disorders, in which the permeability of the BBB is increased. On the other hand due to the relative impermeability of the barrier many drugs are unable to reach the CNS in therapeutically relevant concentration, making the BBB one of the major impediments in the treatment of CNS disorders. The significant scientific and industrial interest in the physiology and pathology of the BBB led to the development of several in vitro models of the BBB. These models are mainly based on the culture of cerebral endothelial cells. The best in vitro models which mimic the best way the in vivo anatomical conditions are the co-culture models in which brain endothelial cells are co-cultured with astrocytes and/or pericytes. Our in vitro BBB model is characterized by high transendothelial electrical resistance (TEER regularily above 200 Ohm times square cm), low permeability and expression of several transporters. Our experiments have proven that the model is suitable for basic research and for testing the interaction between the BBB and potential drug candidates (toxicity, permeability, interaction with efflux transporters) as well.

2 June 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CFCsilla Fazakas
Csilla Fazakas
IWImola Wilhelm
Imola Wilhelm
PNPéter Nagyőszi
Péter Nagyőszi
AFAttila Farkas
Attila Farkas
JHJános Haskó
János Haskó
IKIstván A. Krizbai
István A. Krizbai
Malignant melanoma represents the third common cause of brain metastasis, having the highest propensity to metastasize to the brain of all primary neoplasms in adults. Since the central nervous system lacks a lymphatic system, the only possibility for melanoma cells to reach the brain is via the blood stream and the blood-brain barrier. Despite the great clinical importance, mechanisms of transmigration of melanoma cells through the blood-brain barrier are incompletely understood. In order to investigate this question we have used an in vitro experimental setup based on the culture of cerebral endothelial cells (CECs) and the A2058 and B16/F10 melanoma cell lines, respectively. Melanoma cells were able to adhere to confluent brain endothelial cells, a process followed by elimination of protrusions and transmigration from the luminal to the basolateral side of the endothelial monolayers. The transmigration process of certain cells was accelerated when they were able to use the routes preformed by previously transmigrated melanoma cells. After migrating through the endothelial monolayer several melanoma cells continued their movement beneath the endothelial cell layer. Melanoma cells coming in contact with brain endothelial cells disrupted the tight and adherens junctions of CECs and used (at least partially) the paracellular transmigration pathway. During this process melanoma cells produced and released large amounts of proteolytic enzymes, mainly gelatinolytic serine proteases, including seprase. The serine protease inhibitor Pefabloc® was able to decrease to 44–55% the number of melanoma cells migrating through CECs. Our results suggest that release of serine proteases by melanoma cells and disintegration of the interendothelial junctional complex are main steps in the formation of brain metastases in malignant melanoma.

1 January 2011
Verified
Journal Article
Closed access
Imola WilhelmImola Wilhelm
Imola Wilhelm
CFCsilla Fazakas
Csilla Fazakas
IKIstvan A Krizbai
Istvan A Krizbai

16 September 2008 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
IWImola Wilhelm
Imola Wilhelm
PNPéter Nagyőszi
Péter Nagyőszi
AFAttila Farkas
Attila Farkas
PCPierre‐Olivier Couraud
Pierre‐Olivier Couraud
IRIgnacio Romero
Ignacio Romero
IKIstván A. Krizbai
István A. Krizbai
Because of the relative impermeability of the blood‐brain barrier (BBB), many drugs are unable to reach the CNS in therapeutically relevant concentration. One method to deliver drugs to the CNS is the osmotic opening of the BBB using mannitol. Hyperosmotic mannitol induces a strong phosphorylation on tyrosine residues in a broad spectrum of proteins in cerebral endothelial cells, the principal components of the BBB. Previously, we have shown that among targets of tyrosine phosphorylation are β‐catenin, extracellular signal‐regulated kinase 1/2 and the non‐receptor tyrosine kinase Src. The aim of this study was to identify new signalling pathways activated by hypertonicity in cerebral endothelial cells. Using an antibody array and immunoprecipitation we identified the receptor tyrosine kinase Axl to become tyrosine phosphorylated in response to hyperosmotic mannitol. Besides activation, Axl was also cleaved in response to osmotic stress. Degradation of Axl proved to be metalloproteinase‐ and proteasome‐dependent and resulted in 50–55 kDa C‐terminal products which remained phosphorylated even after degradation. Specific knockdown of Axl increased the rate of apoptosis in hyperosmotic mannitol‐treated cells; therefore, we assume that activation of Axl may be a protective mechanism against hypertonicity‐induced apoptosis. Our results identify Axl as an important element of osmotic stress‐induced signalling.

27 October 2017 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
JSJanina Skipor-Lahuta
Janina Skipor-Lahuta
MTMichal Toborek
Michal Toborek
NAN. Joan Abbott
N. Joan Abbott
DADavid Antonetti
David Antonetti
ESEnming Joe Su
Enming Joe Su
Maria DeliMaria Deli
Maria Deli
Fluids and Barriers of the CNS 2017, 14(Supp 2):A3 The loss of blood-brain barrier (BBB) integrity primarily occurs in cerebral venules and veins during acute hypertensive conditions. Methyl-beta-cyclodextrin (MBCD) causes cholesterol depletion from the cell plasma membrane and leads to caveolar transport disruption. The present study was intended to examine the effects of MBCD

1 May 1999 in Neuroscience Research Communications
Verified
Journal Article
Closed access
PDF file
LNLászló Németh
László Németh
CSCsilla A. Szabó
Csilla A. Szabó
Maria DeliMaria Deli
Maria Deli
JKJózsef Kovács
József Kovács
IKIstván A. Krizbai
István A. Krizbai
CÁCsongor S. Ábrahám
Csongor S. Ábrahám